Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2026)

Organogenesis Holdings has reported Other Non Operating Income over the past 9 years, most recently at -$98000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 262.96% year-over-year to -$98000.0; the TTM value through Dec 2025 reached -$5000.0, down 125.0%, while the annual FY2025 figure was -$5000.0, 125.0% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$98000.0 at Organogenesis Holdings, down from $18000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $73000.0 in Q2 2025 and troughed at -$98000.0 in Q4 2025.
  • A 5-year average of $2894.7 and a median of $5000.0 in 2022 define the central range for Other Non Operating Income.
  • On a YoY basis, Other Non Operating Income climbed as much as 866.67% in 2023 and fell as far as 516.67% in 2023.
  • Year by year, Other Non Operating Income stood at -$19000.0 in 2021, then surged by 131.58% to $6000.0 in 2022, then tumbled by 516.67% to -$25000.0 in 2023, then fell by 8.0% to -$27000.0 in 2024, then crashed by 262.96% to -$98000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for ORGO at -$98000.0 in Q4 2025, $18000.0 in Q3 2025, and $73000.0 in Q2 2025.